Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?

To: William Minich who wrote (89)	1/30/1998 9:38:00 PM
From: harkenman	Read Replies (1) \| Respond to of 207

Value Line starts coverage on Barr Labs on January 30,1998; Rank 2 above average for timeliness with target range of $80 Barr Laboratories Applies To List Stock On NYSE Dow Jones Newswires POMONA, N.Y. -- Barr Laboratories Inc. (BRL) filed an application to list its common stock on the New York Stock Exchange. In a press release Thursday, the company said it anticipates its stock to begin trading on the NYSE in early February under the same symbol it has now, BRL. Barr Laboratories' stock has traded on the American Stock Exchange since 1988. Barr Laboratories develops, makes and markets generic and proprietary pharmaceuticals.